GU Cancer
Advertisement
A recent study offers perspectives from patients and healthcare professionals on telemedicine visits in RCC clinical trials.
A recent survey provides key insights into patient experiences with MIBC treatment and diagnosis over the past decade.
The aim of the research was to assess the combination of epirubicin and mindfulness to treat negative psychological symptoms.
Patients with kidney cancer desire more involvement and shared decision-making with clinicians about their treatment options.
Learn about key barriers to urostomy positioning and how those barriers affect outcomes for patients with bladder cancer.
A new study identified patterns in palliative care use and showed which patients are least likely to receive it.
The real-world study provided insights on patient counseling, prognostics, and therapeutic decision-making processes.
Nursing Implications of the FDA Withdrawal of Sacituzumab Govitecan for Metastatic Urothelial Cancer
Learn how oncology nurses can address patient questions about the withdrawal and help them navigate the path forward.
Mobile internet management for post-prostatectomy care improved disease knowledge, mental well-being, and quality of life.
A recent study shows that fear of cancer recurrence in patients with prostate cancer has a serious impact on functionality.
Researchers are illuminating why clinical nurse specialists are "best placed to offer holistic care" for these patients.
A system based on two prognostic factors can predict the outcomes of these patients.
A quantitative-qualitative survey provided insights on patient experiences, emotions, and perceptions
Research presented at JADPRO Live provided insights into patient preferences surrounding treatment administration.
The study analyzed how decision making and quality of life contribute to treatment regret in patients with prostate cancer.
The integrative literature review evaluated clinician and patient experiences and outcomes for nurse-led flexible cystoscopy.
The multi-site, retrospective study assessed patients with advanced urothelial carcinoma and neuropathy or diabetes mellitus.
The first-of-its kind clinical trial was presented at the 2024 ASTRO Annual Meeting.
A team used an interpretive description approach to evaluate the self-management support intervention.
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.